Keywords: ضد عامل Xa; Enoxaparin; Deep venous thrombosis; Anti-factor Xa; Prophylaxis; Trauma;
مقالات ISI ضد عامل Xa (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ضد عامل Xa; CPB; cardiopulmonary bypass; TG; thrombin generation; CAT; calibrated automated thrombography; TFPI; tissue factor pathway inhibitor; AT; antithrombin; CABG; coronary artery bypass grafting; ACT; activated clotting time; UFH; unfractionated heparin; PPP;
Utility of anti-factor Xa monitoring in surgical patients receiving prophylactic doses of enoxaparin for venous thromboembolism prophylaxis
Keywords: ضد عامل Xa; Enoxaparin; Drug metabolism; Anti-factor Xa; Venous thromboembolism; Deep venous thrombosis; Pulmonary embolus;
Coagulation factor abnormalities related to discordance between anti-factor Xa and activated partial thromboplastin time in patients supported with continuous-flow left ventricular assist devices
Keywords: ضد عامل Xa; ventricular assist device; heparin; anti-factor Xa; activated partial thromboplastic time; PTT; coagulation factors; device thrombosis; hemolysis; bleeding; anti-coagulation; warfarin;
Full Length ArticleIs anti-factor Xa chromogenic assay for Rivaroxaban appropriate in clinical practice? Advantages and comparative drawbacks
Keywords: ضد عامل Xa; Rivaroxaban; HPLC-MSMS; Chromogenic assay; Anticoagulant; Anti-factor Xa;
Anti–Factor Xa and Activated Partial Thromboplastin Time Measurements for Heparin Monitoring in Mechanical Circulatory Support
Keywords: ضد عامل Xa; activated partial thromboplastin time; anti-factor Xa; continuous-flow left ventricular assist device; intravenous unfractionated heparin; monitoringanti-FXa, anti–factor Xa; aPTT, activated partial thromboplastin time; CF-LVAD, continuous-flow left ventr
No correlation between anti-factor Xa levels, low-molecular-weight heparin, and bleeding after gastric bypass
Keywords: ضد عامل Xa; Anti-factor Xa; Low-molecular-weight heparin; Thromboprophylaxis; Gastric bypass; Postoperative transfusion;
Age-related differences in heparin response
Keywords: ضد عامل Xa; Anti-Factor Xa; Anti-Factor IIa; APTT; Children; Heparin
Validation of the anti-factor IIa assay and potency assessment of enoxaparin in pharmaceutical formulations
Keywords: ضد عامل Xa; Enoxaparin; Anti-factor IIa; Anti-factor Xa; Validation; Low molecular weight heparin;